David Lyden
- Cancer Research top 0.05%
- MicroRNA in disease regulation 10
- Cancer, Hypoxia, and Metabolism 7
- Oncology top 0.2%
- Cancer Cells and Metastasis 18
- Genetics top 0.2%
- Glioma Diagnosis and Treatment 8
- Mesenchymal stem cell research 8
- Molecular Biology top 0.2%
- Extracellular vesicles in disease 26
- Angiogenesis and VEGF in Cancer 17
- Immunology and Allergy top 0.5%
-
- Brain Metastases and Treatment 6
- Co-authors
- Shahin RafiiBethan PsailaHéctor PeinadoRosandra N. KaplanBeate HeissigRobert BenezraKoichi HattoriSérgio Dias
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- United StatesPortugalSpain
In The Last Decade
David Lyden
101 papers receiving 21.1k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 6.5k
- Oncology 7.0k
- Genetics 2.6k
- Molecular Biology 12.7k
- Immunology and Allergy 953
Countries citing papers authored by David Lyden
This map shows the geographic impact of David Lyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lyden more than expected).
Fields of papers citing papers by David Lyden
This network shows the impact of papers produced by David Lyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lyden. The network helps show where David Lyden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Lyden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 23 | |
| 3 | Immune determinants of the pre-metastatic nichebreakdown → | 2023 | 115 |
| 4 | 2022 | 44 | |
| 5 | 2022 | 71 | |
| 6 | 2021 | 71 | |
| 7 | 2020 | 21 | |
| 8 | 2019 | 38 | |
| 9 | 2019 | 17 | |
| 10 | 2018 | 160 | |
| 11 | 2017 | 17 | |
| 12 | 2016 | 23 | |
| 13 | 2016 | 117 | |
| 14 | 2016 | 15 | |
| 15 | 2013 | 44 | |
| 16 | The perivascular niche regulates breast tumour dormancybreakdown → | 2013 | 843 |
| 17 | 2012 | 112 | |
| 18 | 2011 | 15 | |
| 19 | Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosisbreakdown → | 2003 | 1232 |
| 20 | 1998 | 180 |
About David Lyden
David Lyden is a scholar working on Genetics, Cancer Research and Oncology, having authored 104 papers that have together received 21.4k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (26 papers), Cancer Cells and Metastasis (18 papers), Angiogenesis and VEGF in Cancer (17 papers), MicroRNA in disease regulation (10 papers), Glioma Diagnosis and Treatment (8 papers), Mesenchymal stem cell research (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Brain Metastases and Treatment (6 papers). The work is most often cited by research in Cancer Research (6.5k citations), Oncology (7.0k citations) and Genetics (2.6k citations). David Lyden has collaborated with scholars based in United States, Portugal and Spain. Frequent co-authors include Shahin Rafii, Bethan Psaila, Héctor Peinado, Rosandra N. Kaplan, Beate Heissig, Robert Benezra, Koichi Hattori, Sérgio Dias, Neil R. Hackett and Ronald G. Crystal. Their work appears in journals such as Cancer Research, Pediatric Blood & Cancer, Nature Medicine, Nature reviews. Cancer and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.